Retinal cells grown from stem cells can reach out and connect with neighbors, according to a new study, completing a “handshake” that may show the cells are ready for clinical trials....
Highly anticipated study results are expected in Alzheimer’s, obesity and Huntington’s disease, while a pair of high-priced acquisitions could be put to the test....
The biomedical sciences were well represented among Science’s 2022 breakthroughs. Some of these innovations benefited, directly or indirectly, from NIH efforts and support....
Children and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact....
Achieving clinical trial diversity will require a multi-stakeholder approach across the healthcare ecosystem, including efforts by government agencies, health systems, and industry....
The Food and Drug Administration has approved Sunlenca, an injectable therapy to suppress HIV for patients who suffered drug resistance to other regimens....
A recent report highlights why Black people may be hesitant to participate in clinical trials that test health care technology, vaccines, and medical treatments....
While the use of digital health technologies has increased in clinical trials, securing patients' trust continues to be a significant challenge. These technologies may help build trust by helping to increase representation in clinical trials....
A handful of rare diseases are being targeted with mRNA therapeutics....
Instead of cutting out chunks of the genome to disable malfunctioning genes, base editing makes a smaller, more precise swap....
